Guardant Health, Inc. filed a Form 8-K on November 3, 2026, disclosing the appointment of Kevin R. Sayer as a Class II director and Robert A. Parks as Chief Accounting Officer, both effective November 2, 2026.

Key Highlights

  • Board expanded: Guardant Health's Board of Directors increased its size to 11 members to accommodate the new appointment.
  • Kevin R. Sayer, age 68, was appointed as a Class II director with a term expiring at the 2029 Annual Meeting of Stockholders.
  • Sayer's director compensation includes a restricted stock unit award valued at $500,000 and a cash retainer of $60,000 per year.
  • RSU vesting schedule: one-third vests on the first anniversary of appointment, with the remaining two-thirds vesting over the following two annual anniversaries.
  • Robert A. Parks, age 54, was appointed Chief Accounting Officer and assumed the role of principal accounting officer.
  • Parks's most recent role was Chief Accounting Officer of Fortrea Holdings Inc., from August 2024 to August 2026.

Guardant Health Adds Medical Technology Executive and Seasoned Accounting Officer

According to the filing, Guardant Health (NASDAQ:GH) appointed Kevin R. Sayer to its Board of Directors on November 2, 2026, increasing the total number of board members to 11. Mr. Sayer will serve as a Class II director until the 2029 Annual Meeting of Stockholders, or until his successor is duly elected and qualified, or until his earlier death, resignation, or removal. The filing states that there are no arrangements or understandings between Mr. Sayer and any other person pursuant to which he was selected as a director.

The filing describes Mr. Sayer's professional background as including service as President and Chief Executive Officer of Dexcom, Inc. from January 2015 to January 2026, and as Executive Chairman of the Board of Dexcom effective January 1, 2026. He has served on the Dexcom board since November 2007 and as Chairperson since July 2018. Earlier roles cited in the filing include Chief Financial Officer of Biosensors International Group, Ltd. from April 2007 to December 2010, and executive positions at Specialty Laboratories, Inc. and MiniMed, Inc. Mr. Sayer holds a Master's Degree in Accounting and Information Systems and a B.A., both from Brigham Young University, and is a Certified Public Accountant (inactive).

Separately, the filing disclosed that the Board appointed Robert A. Parks as Chief Accounting Officer and principal accounting officer on November 2, 2026. The filing notes that Mr. Parks previously served as Chief Accounting Officer of Fortrea Holdings Inc. from August 2024 to August 2026, Chief Accounting Officer of SailPoint Technologies Holdings, Inc. from September 2023 to August 2024, Chief Accounting Officer of NetApp, Inc. from 2021 to September 2023, and Chief Accounting Officer of Syneos Health, Inc. from 2018 to 2021. He also held positions at IQVIA Holdings, Inc. from 2011 to 2018, including Senior Vice President, Corporate Controller and Principal Accounting Officer. The filing states that Mr. Parks began his career at Ernst & Young LLP and holds a B.S. in Accounting from the University of Maryland, College Park.

What Was Disclosed

Guardant Health reported the appointment of Kevin R. Sayer as a Class II director and Robert A. Parks as Chief Accounting Officer and principal accounting officer, both effective November 2, 2026, along with their respective compensation arrangements and professional backgrounds.